Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

noul co., ltd. (376930.KQ)

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
8,380.00-20.00 (-0.24%)
As of 10:36AM KST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8,400.00
Open8,500.00
Bid8,350.00 x N/A
Ask8,370.00 x N/A
Day's Range8,130.00 - 9,160.00
52 Week Range8,130.00 - 9,160.00
Volume1,897,817
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 376930.KQ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Biotech Company Noul Participates ASTMH, Giving Presentation at a Scientific Session

      Noul Co., Ltd. (CEO: David Lim), a Biotech Company, announced that it will participate in the 2022 American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting held from October 30 to November 3 in Seattle, USA. Noul plans to introduce the innovativeness of malaria products and explore market opportunities in the public sector by participating in the ASTMH annual meeting.

    • PR Newswire

      Noul's Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed

      A new study by Noul Co., Ltd., (376930.KR), a KOSDAQ-listed biotech startup, Harvard Medical School and Massachusetts Clinical Hospital was published in American Chemical Society Applied Materials and Interfaces, a renowned academic journal.

    • PR Newswire

      Biotech Startup Noul Releases 2021 Sustainability Report

      Noul Co., Ltd., (376930.KR), a KOSDAQ-listed biotech startup, has released its 2021 Sustainability Report, including corporate sustainability performances. Through the report, Noul reviews its economic, social, and environmental business activities, identifies the value and impact, and reports to the stakeholders every year. The report is the second publication after 2020.

    Advertisement
    Advertisement